https://www.avient.com/news/archives?page=46
Avient Announces First Quarter 2025 Results...
Avient To Hold First Quarter 2025 Conference Call...
Avient Announces Fourth Quarter and Full Year 2024 Results...
https://www.avient.com/news/archives?page=45
Avient Announces First Quarter 2025 Results...
Avient To Hold First Quarter 2025 Conference Call...
Avient Announces Fourth Quarter and Full Year 2024 Results...
https://www.avient.com/news/archives?page=40
Avient Announces First Quarter 2025 Results...
Avient To Hold First Quarter 2025 Conference Call...
Avient Announces Fourth Quarter and Full Year 2024 Results...
https://www.avient.com/news/archives?page=50
Avient Announces First Quarter 2025 Results...
Avient To Hold First Quarter 2025 Conference Call...
Avient Announces Fourth Quarter and Full Year 2024 Results...
https://www.avient.com/sites/default/files/2023-05/Mevopur Amber for PET Pharma Pkg Application Bulletin_CN _2.pdf
主要特性
在四个通过ISO 13485认证的医疗生产线生
产,拥有全球统一的配方,提供一致性和供
应链保障
变更控制记录的不限于CAS编号级别,降低变
更风险
不含动物源性物质和邻苯二甲酸盐
不同的琥珀色色调,可根据要求定制—偏红色
或偏黄色,和/或颜色浅或深
适用于液体形式
•
•
•
•
•
法规支持
经过预测试的原材料:
- ISO 10993-1和USP第、
部分(VI级)
- 欧洲药典,,美国药典,
元素分析符合ICH Q3D
- USP 溶液性状、颜色标准
FDA发布的注册药品主文件(III类)
食品接触符合FDA/EU*要求
符合YBB00102002-2015 (口服液体药用聚酯
瓶)标准
•
•
•
•
1.844.4AVIENT
www.avient.com
适用医疗保健使用限制—见下文。
https://www.avient.com/sites/default/files/2022-09/Avient Discontinued Operations Financial Information.pdf
Microsoft PowerPoint - Avient Discontinued Operations Financial Information
AVIENT CORPORATION
R E C A S T F I N A N C I A L I N F O R M A T I O N T O
R E F L E C T D I S T R I B U T I O N A S A
D I S C O N T I N U E D O P E R A T I O N
(NYSE: AVNT)
S E P T E M B E R 2 7 , 2 0 2 2
TAB LE OF CONTENTS
Avient Corporation 2
Slide 3 - GAAP Income Statement Recast for Avient Distribution as a Discontinued Operation
Reflects US GAAP (GAAP) Income Statements recast for Avient Distribution as a discontinued operation.
Slide 5 - Segment Data Recast for Avient Distribution as a Discontinued Operation
Reflects segment data recast for Avient Distribution as a discontinued operation.
Certain corporate costs previously allocated to Avient Distribution will be retained by Avient and have been recast as costs in
continuing operations.
https://www.avient.com/investor-center/investor-news/archives?page=17
CLEVELAND, Dec. 19, 2019 /PRNewswire/ -- PolyOne Corporation (NYSE: POL), a leading global provider of specialized polymer materials, services and s
CLEVELAND, Dec. 19, 2019 /PRNewswire/ -- PolyOne Corporation (NYSE: POL), a leading global provider of specialized polymer materials, services and s
CLEVELAND, Oct. 28, 2019 /PRNewswire/ -- PolyOne Corporation (NYSE: POL), a premier global provider of specialized polymer materials, services
https://www.avient.com/investor-center/investor-news/archives?page=28
CLEVELAND, July 6, 2017 /PRNewswire/ -- PolyOne Corporation (NYSE: POL), a premier global provider of specialized polymer materials, servi
CLEVELAND, June 29, 2017 /PRNewswire/ -- PolyOne Corporation (NYSE: POL), a premier global provider of specialized polymer materials, serv
CLEVELAND, May 11, 2017 /PRNewswire/ -- PolyOne Corporation (NYSE: POL), a leading global provider of specialized polymer materials, services and so
https://www.avient.com/industries/packaging/cosmetics-packaging/fragrance
Comprehensive overview of Avient technologies for applications within the B&C industry
Avient Design
Sync design with manufacturability: Learn about how Avient Design can help simplify your new product development process
https://www.avient.com/industries/packaging/cosmetics-packaging/applicators
Comprehensive overview of Avient technologies for applications within the B&C industry
Avient Design
Sync design with manufacturability: Learn about how Avient Design can help simplify your new product development process